| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07393282 A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering… |
Recruitment opened |
| 2026-06-11 | NCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… |
Recruitment opened |
| 2026-06-11 | NCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… |
Trial sites expanded: 0 -> 6 locations |
| 2026-06-11 | NCT07477704 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult… |
date change Primary completion pushed: 2026-10-20 -> 2026-12-29 |
| 2026-06-09 | NCT06975787 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… |
date change Primary completion pushed: 2028-07-23 -> 2029-09-09 |
| 2026-06-09 | NCT06975787 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… |
date change Completion pushed: 2028-07-23 -> 2029-09-09 |
| 2026-06-05 | NCT04287621 Registry of Asthma Patients Initiating DUPIXENT® |
Trial completed |
| 2026-06-05 | NCT06140524 A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma… |
Trial sites expanded: 20 -> 39 locations |
| 2026-06-04 | NCT07213778 REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee… |
Primary endpoint(s) modified |
| 2026-06-04 | NCT07213778 REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee… |
Trial sites expanded: 16 -> 19 locations |
| 2026-06-03 | NCT05092347 A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-03 | NCT05092347 A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic… |
Enrollment reduced: 56 -> 43 participants |
| 2026-06-03 | NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients… |
Trial completed |
| 2026-06-03 | NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients… |
date change Primary completion moved earlier: 2026-05-31 -> 2026-04-29 |
| 2026-06-03 | NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients… |
date change Completion moved earlier: 2026-05-31 -> 2026-04-29 |
| 2026-05-30 | NCT07318597 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) |
Trial sites expanded: 3 -> 6 locations |
| 2026-05-30 | NCT07430956 Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation… |
Trial sites expanded: 5 -> 13 locations |
| 2026-05-30 | NCT07543055 A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer… |
date change Completion pushed: 2030-11-04 -> 2031-03-20 |
| 2026-05-30 | NCT07493304 Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants… |
Recruitment opened |
| 2026-05-28 | NCT07410117 REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-08 | NCT07631637 Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated… | Phase 2 | Not Yet Recruiting |
| 2026-06-04 | NCT07626411 Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation | Phase 3 | Not Yet Recruiting |
| 2026-05-27 | NCT07609940 Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of… | Phase 4 | Not Yet Recruiting |
| 2026-05-18 | NCT07594093 Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity | Phase 1 | Not Yet Recruiting |
| 2026-05-18 | NCT07594106 REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in… | Phase 1/2 | Not Yet Recruiting |
| 2026-05-14 | NCT07587658 This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is… | Phase 4 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07142343 | A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age… | CHAPLE Disease | Recruiting |
| NCT07587658 | This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is… | Chronic Obstructive Pulmonary Disease (COPD) | Not Yet Recruiting |
| NCT06572228 | Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting… | Asthma | Active, Not Recruiting |
| NCT07609940 | Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of… | Relapsed/Refractory Multiple Myeloma (RRMM) | Not Yet Recruiting |
| Phase 3 | |||
| NCT07309432 | Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With… | Allergic Conjunctivitis | Recruiting |
| NCT05730036 | A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab… | Relapsed Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07220772 | A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in… | Monogenic Obesity | Recruiting |
| NCT05744921 | A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT06149286 | A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better… | Relapsed/Refractory Follicular Lymphoma | Recruiting |
| NCT06246916 | A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants… | Melanoma | Recruiting |
| NCT07015905 | REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee… | Venous Thromboembolism (VTE) | Recruiting |
| NCT07220785 | Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized… | Generalized Lipodystrophy | Recruiting |
| NCT06091865 | A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… | Diffuse Large B-cell Lymphoma (DLBCL) | Recruiting |
| NCT06091254 | A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works… | Follicular Lymphoma (FL) | Recruiting |
| NCT07112378 | A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food… | Eosinophilic Esophagitis (EoE) | Recruiting |
| NCT07318610 | Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With… | Peripheral Artery Disease (PAD) | Recruiting |
| NCT07154745 | A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting |
| NCT06541704 | A Study Investigating Subcutaneously Administered Pozelimab in Combination With… | Age-related Macular Degeneration (AMD) | Recruiting |
| NCT07410117 | REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis | Cancer-Associated Thrombosis (CAT) | Recruiting |
| NCT07430956 | Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation… | Atrial Fibrillation (AF) | Recruiting |
| NCT07493304 | Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants… | Venous Thromboembolism (VTE) | Recruiting |
| NCT07222761 | A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination… | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Recruiting |
| NCT07213778 | REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee… | Symptomatic Venous Thromboembolism (VTE) | Recruiting |
| NCT06585410 | Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous… | Cutaneous Squamous Cell Carcinoma (CSCC) | Recruiting |
| NCT07393282 | A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering… | High Risk Smoldering Multiple Myeloma (HR-SMM) | Recruiting |